Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanara MedTechSMTI -3.02%72 EV-to-FCF is 76.34 as of Jul. 14, 2026. GuruFocus rates SMTI with a GF Score™ of 72/100 and a GF Value™ of $45.74 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Sanara MedTech ranks worse than 83.09% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sanara MedTech's Enterprise Value is $255.8 Mil.
Sanara MedTech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $3.4 Mil. Therefore, Sanara MedTech's EV-to-FCF for today is 76.34.
The historical rank and industry rank for Sanara MedTech's EV-to-FCF or its related term are showing as below:
SMTI'
s EV-to-FCF Range Over the Past 10 Years
Min: -1309.54 Med: -33.55 Max: 9440.66
Current: 76.34
During the past 13 years, the highest EV-to-FCF of Sanara MedTech was 9440.66. The lowest was -1309.54. And the median was -33.55.
SMTI's EV-to-FCF is ranked worse than 83.09% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs SMTI: 76.34
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sanara MedTech's PE Ratio (TTM) for today is calculated as:
Sanara MedTech's share price for today is $24.115.
Sanara MedTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.890.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sanara MedTech EV-to-FCF Related Terms
Sanara MedTech EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sanara MedTech's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Sanara MedTech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanara MedTech EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sanara MedTech's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sanara MedTech's EV-to-FCF falls into.
Sanara MedTech's current Enterprise Value is $255.8 Mil.
Sanara MedTech's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanara MedTech (SMTI) has a EV-to-FCF of 76.34 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sanara MedTech and its competitors. According to the industry distribution chart, Sanara MedTech ranks #344 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 83.1%.
Is Sanara MedTech's EV-to-FCF too high?
Sanara MedTech's current EV-to-FCF is 76.34. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. Sanara MedTech's value of 76.34 is 225.6% above this industry median. Based on the distribution chart, Sanara MedTech ranks #344 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sanara MedTech has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sanara MedTech's EV-to-FCF compare to EMBC and KRMD?
According to the Medical Devices & Instruments industry distribution chart, Sanara MedTech ranks #344 out of 414 companies for EV-to-FCF. This places Sanara MedTech in the lower half of its industry. The industry median EV-to-FCF is 23.45. Sanara MedTech's value of 76.34 is 225.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanara MedTech's current EV-to-FCF of 76.34 is 225.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sanara MedTech and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanara MedTech's current EV-to-FCF is 76.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanara MedTech stock overvalued right now?
Based on GuruFocus' analysis, Sanara MedTech (SMTI) is currently considered Possible Value Trap. The stock's GF Value™ is $45.74, compared to a current price of $24.12 — trading 47.3% below its estimated fair value. The current EV-to-FCF is 76.34 and 225.6% above the Medical Devices & Instruments industry median of 23.45. Sanara MedTech's overall GF Score™ is 72/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sanara MedTech (SMTI), the current EV-to-FCF is 76.34 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanara MedTech (SMTI) Overvalued in 2026?
Based on GuruFocus' analysis, Sanara MedTech stock appears to be undervalued.
The current stock price of $24.12 is trading 47.3% below its estimated GF Value™ of $45.74.
GuruFocus considers Sanara MedTech to be Possible Value Trap.
Key valuation signals for SMTI:
EV-to-FCF: 76.34
GF Value™: $45.74 vs. price of $24.12 (47.3% below fair value)
Industry Position: 225.6% above the Medical Devices & Instruments median (#344 of 414)
No single metric tells the full story. See the SMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
72GF Score
Get the complete analysis for SMTI
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMTI has been successfully added to your 
